Rivasa 81 Mg Ec Tablet; Out Of Specification (salicylic Acid Impurity)
Rivasa 81 mg EC Tablet Recall Rivasa 81 mg EC tablets are being recalled across Canada because they contain higher-than-acceptable levels of salicylic acid impurity, which is a quality issue. This recall affects all Rivasa 81 mg EC tablets distributed in Canada. The recall is classified as Class I, which is the most serious classification.
- Product
- RIVASA 81mg EC tablet
- Reason
- Product quality
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2025-06-06
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/0c462a97-188a-4756-897a-33a561d8fd6b